47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
68.20.Z - Rental and management of own or leased real estate
70.22.Z - Head office activities and management consultancy
73.12.B - Advertising through mass media
73.12.C - Advertising through mass media
73.12.D - Advertising through mass media
2022 | 2023 | ||
---|---|---|---|
M PLN | M PLN | % | |
Gross profit (loss) | 0,8 | 0,7 | -12,8 |
EBITDA | 1,1 | 1 | -8,6 |
Short time liabilities | 0,6 | 0,6 | -4,1 |
Equity capital | 4 | 4,3 | 7,6 |
Operating profit (EBIT) | 1 | 0,8 | -11,1 |
Assets | 6,2 | 6,1 | -1 |
Net profit (loss) | 0,8 | 0,7 | -12,8 |
Cash | 0,2 | 0,2 | 13,4 |
Net income from sale | 7,8 | 8 | 2,9 |
Liabilities and provisions for liabilities | 2,2 | 1,9 | -16,4 |
Working assets | 0,6 | 0,7 | 12,2 |
Depreciation | 0,2 | 0,2 | 6,1 |
% | % | p.p. | |
Profitability of capital | 20,9 | 16,9 | -4 |
Equity capital to total assets | 64,2 | 69,7 | 5,5 |
Gross profit margin | 10,6 | 9 | -1,6 |
EBITDA Margin | 14,2 | 12,7 | -1,5 |
Days | Days | Days | |
Short term commitment turnover cycle | 29 | 27 | -2 |
Current financial liquidity indicator | 1.0280873775482178 | 1.2018399238586426 | 0,2 |
Net dept to EBITDA | 1.2690485715866089 | 1.0346970558166504 | -0,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane